Glycoprotein B of human cytomegalovirus promotes virion penetration into cells, transmission of infection from cell to cell, and fusion of infected cells
- PMID: 7692667
- DOI: 10.1006/viro.1993.1575
Glycoprotein B of human cytomegalovirus promotes virion penetration into cells, transmission of infection from cell to cell, and fusion of infected cells
Abstract
Human cytomegalovirus (HCMV) glycoprotein B (gB) is an abundant glycoprotein in the virion envelope that elicits neutralizing antibodies in human infection and in immunized animals. Using a panel of monoclonal antibodies to gB with neutralizing activity, we analyzed in detail the mechanisms by which these antibodies block HCMV infection. Twelve antibodies with complement-independent neutralizing activity were studied for their effect on the attachment of virions to the cell surface, virion penetration into cells, the transmission of infection from cell to cell, and fusion of infected cells. All of the complement-independent antibodies blocked penetration of virions into cells but had no effect on virion attachment to the cell surface. The most potent neutralizing antibodies also limited the spread of infection from cell to cell. Fusion of HCMV-infected U373 glioblastoma cells was blocked by all but two of the neutralizing antibodies to gB, suggesting that fusion of infected cells is similar but not identical to the fusion of the virion envelope with the cell membrane that occurs during virion entry. Our findings provide the first evidence that HCMV gB is a multifunctional glycoprotein that promotes virion penetration into cells, the transmission of infection from cell to cell, and fusion of infected U373 cells.
Similar articles
-
Function of human cytomegalovirus glycoprotein B: syncytium formation in cells constitutively expressing gB is blocked by virus-neutralizing antibodies.Virology. 1994 Jun;201(2):263-76. doi: 10.1006/viro.1994.1291. Virology. 1994. PMID: 8184537
-
Mutated forms of human cytomegalovirus glycoprotein B are impaired in inducing syncytium formation.Virology. 1995 Jun 1;209(2):580-91. doi: 10.1006/viro.1995.1290. Virology. 1995. PMID: 7778290
-
Humoral immune response to functional regions of human cytomegalovirus glycoprotein B.J Med Virol. 1997 Aug;52(4):451-9. J Med Virol. 1997. PMID: 9260696
-
Human cytomegalovirus glycoprotein-receptor interactions.Transplant Proc. 1991 Jun;23(3 Suppl 3):60-3. Transplant Proc. 1991. PMID: 1648838 Review.
-
The role of herpes simplex virus glycoproteins in the virus replication cycle.Acta Virol. 1998 Apr;42(2):103-18. Acta Virol. 1998. PMID: 9770079 Review.
Cited by
-
Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation.BMC Infect Dis. 2013 Jul 10;13:310. doi: 10.1186/1471-2334-13-310. BMC Infect Dis. 2013. PMID: 23841715 Free PMC article.
-
Persistent Cytomegalovirus Infection in Amniotic Membranes of the Human Placenta.Am J Pathol. 2016 Nov;186(11):2970-2986. doi: 10.1016/j.ajpath.2016.07.016. Epub 2016 Sep 13. Am J Pathol. 2016. PMID: 27638253 Free PMC article.
-
Evasion of a Human Cytomegalovirus Entry Inhibitor with Potent Cysteine Reactivity Is Concomitant with the Utilization of a Heparan Sulfate Proteoglycan-Independent Route of Entry.J Virol. 2020 Mar 17;94(7):e02012-19. doi: 10.1128/JVI.02012-19. Print 2020 Mar 17. J Virol. 2020. PMID: 31941787 Free PMC article.
-
The human cytomegalovirus UL55 (gB) and UL75 (gH) glycoprotein ligands initiate the rapid activation of Sp1 and NF-kappaB during infection.J Virol. 1997 Jul;71(7):5051-9. doi: 10.1128/JVI.71.7.5051-5059.1997. J Virol. 1997. PMID: 9188570 Free PMC article.
-
Concurrent genotyping and quantitation of cytomegalovirus gB genotypes in solid-organ-transplant recipients by use of a real-time PCR assay.J Clin Microbiol. 2008 Dec;46(12):4004-10. doi: 10.1128/JCM.01341-08. Epub 2008 Oct 29. J Clin Microbiol. 2008. PMID: 18971365 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources